GMPharma Consult ApS

CVR 42760137 · Private limited company (ApS) · Active · Medium risk

GMPharma Consult ApS is a Private limited company (ApS), founded on , based in Hillerød. The company is registered in the industry anden teknisk rådgivning. Our model estimates a bankruptcy risk of 1.8% over the next 12 months, which is 1.3 times the average for Danish companies. 4 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 59k and a net result of DKK -29k. CEO: Ina Maria Carolina Glamheden-Helle.

Bankruptcy risk for GMPharma Consult ApS

1.8%
probability of bankruptcy within 12 months
Medium risk

1.3 × the average (1.41%) · higher risk than 81% of active Danish companies

Lowest riskHighest risk

Increases the risk

Share of late annual reports75%+ · bankruptcy rate 29.8%3.4×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Equity vs. share capital1× · bankruptcy rate 12.9%1.5×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×

Reduces the risk

Reinstated after compulsory dissolutionYes · bankruptcy rate 0.0%0.00×
Current ratio500%+ · bankruptcy rate 1.5%0.17×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Negative equityNo · bankruptcy rate 5.1%0.58×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42760137
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
Lyngbakken 42
3400 Hillerød
Municipality
Hillerød
Industry
Anden teknisk rådgivning (711290)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder
Share capital
DKK 40k
Auditor
Nærrevision A/S
Audit opted out
Yes

Warning signs

Annual reports filed late4 of 4
Missing annual reportNo
Negative equityNo
Equity ratio81.3%
Current ratio534%
Moves (last 2 years)0
CEO changes in total2
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK -11kDKK -35kDKK -14k
Net profitDKK -29kDKK -39kDKK -13k
EquityDKK 59kDKK 88kDKK 128k
Total assetsDKK 73kDKK 119kDKK 166k
CashDKK 24kDKK 77k–
Short-term debtDKK 14kDKK 31k–
Avg. employees00–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Nærrevision A/S.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025187 Late
1 Jan 2024 – 31 Dec 2024198 Late
1 Jan 2023 – 31 Dec 2023323 Late
1 Oct 2021 – 31 Dec 2022213 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOIna Maria Carolina Glamheden-HelleCurrent
CEOIna Glamheden-Helle
Owner (100%)Startplattan 192299 AktiebolagCurrent
FounderStartplattan 192299 AktiebolagCurrent

Address history (0 moves)

Lyngbakken 42, 3400 Hillerød

Similar companies in Hillerød

Questions and answers about GMPharma Consult ApS

Has GMPharma Consult ApS gone bankrupt?

No, GMPharma Consult ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of GMPharma Consult ApS?

Our model estimates a bankruptcy risk of 1.8% over the next 12 months (medium risk), which is 1.3 times the average for Danish companies.

Who is the CEO of GMPharma Consult ApS?

Ina Maria Carolina Glamheden-Helle is the CEO of GMPharma Consult ApS.

Who is the auditor of GMPharma Consult ApS?

GMPharma Consult ApS most recently used Nærrevision A/S.

When was GMPharma Consult ApS founded?

GMPharma Consult ApS was founded on 1 October 2021.

What is the equity of GMPharma Consult ApS?

Equity was DKK 59k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.